indazoles has been researched along with pp242 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, X; Liu, H; Qian, W; Wei, J; Xiao, F; Yang, C; You, L | 1 |
1 other study(ies) available for indazoles and pp242
Article | Year |
---|---|
PDK1 inhibitor GSK2334470 exerts antitumor activity in multiple myeloma and forms a novel multitargeted combination with dual mTORC1/C2 inhibitor PP242.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Female; Humans; Indazoles; Indoles; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice; Mice, SCID; Multiple Myeloma; Purines; Pyrimidines; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2017 |